The size of the North America Cell Fractionation Market was valued at USD 0.9 Billion in 2020. It is further estimated to be growing at a CAGR of 10.65% and worth USD 1.49 billion by 2025.
The market is expected to grow at a significant pace in the forecasting period. It will also grow in the future years to follow because of recent developments in the biotechnology sector.
Cell fractionation, also known as Cell Lysis, is the separation of cellular parts yet the complete retaining of independent features of each part. It involves the breaking of the cell membrane through different mechanisms. Cell fractionation helps scientists study the various parts of cells individually and identify their biochemical function and structure.
The major driving forces of the growth of the Cell Fractionation market in North America are an increase in the geriatric population and growing government support in funding. There is also a development in the biotechnology sector, especially R & D activities, thus propelling the Cell Fractionation market's growth. The only major constraints for this market are a high requirement of capital as well as time.
This research report has been segmented and sub-segmented the North America Cell Fractionation Market into the following categories.
By Product:
By Cell Type:
By End User:
By Country:
Based on region, the North American market is segmented into U.SA and Canada. The U.S.A market has undergone a lot of development due to the increased focus on R & D activities in the biotechnology sector.
Some of the promising companies leading the North American cell fractionation market profiled in the report are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Reagents
5.1.3.1 Enzymes
5.1.3.2 Detergent Solutions
5.1.4 Beads
5.1.5 Disposables
5.1.6 Instruments
5.1.6.1 Sonicator
5.1.6.2 Homogenizer
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Type of cell
5.2.1 Introduction
5.2.2 Microbial
5.2.3 Mammalian
5.2.4 Y-o-Y Growth Analysis, By Type of cell
5.2.5 Market Attractiveness Analysis, By Type of cell
5.2.6 Market Share Analysis, By Type of cell
5.3 End Users
5.3.1 Introduction
5.3.2 Research Laboratories and Institutes
5.3.3 Biopharmaceutical Companies
5.3.4 iotechnology Companies
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Bio-Rad Laboratories
8.5 Cell Signaling Technology
8.6 Miltenyi Biotec
8.7 Thermo Fisher Scientific Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
Related Reports
Feb 2020
